Your institution may have access to this item. Find your institution then sign in to continue.
Title
FDA actions in brief.
Abstract
The article presents news briefs on drugs approved by the U.S. Food and Drug Administration. Included are the Naltrexone extended-release injectable suspension (Vivitrol) of Alkermes Inc. and Cephalon Inc., for the treatment of alcohol independence, and the Zanamivir inhalation powder (Relenza), of GlaxoSmithKline Pharmaceuticals Ltd., for the prevention of influenza A and B infections in children.